Ex vivo expansion of regulatory T cells from long-term Belatacept-treated kidney transplant patients restores their phenotype and suppressive function but not their FOXP3 TSDR demethylation status
Author:
Funder
CONACyT
Publisher
Elsevier BV
Subject
Immunology
Reference68 articles.
1. Recent advances in immunosuppression and acquired immune tolerance in renal transplants;Casiraghi;Am. J. Physiol. Renal. Physiol.,2016
2. Complications of immunosuppressive agents therapy in transplant patients;Reske;Minerva Anestesiol.,2015
3. Belatacept As an alternative to calcineurin inhibitors in patients with solid organ transplants;Kumar;Front. Med.,2017
4. Belatacept and long-term outcomes in kidney transplantation;Vincenti;N. Engl. J. Med.,2016
5. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study);Vincenti;Am. J. Transplant.,2010
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tregs in transplantation tolerance: role and therapeutic potential;Frontiers in Transplantation;2023-08-30
2. Treg Therapy for the Induction of Immune Tolerance in Transplantation—Not Lost in Translation?;International Journal of Molecular Sciences;2023-01-16
3. Regulatory T cell homeostasis: Requisite signals and implications for clinical development of biologics;Clinical Immunology;2023-01
4. Bacterial and Viral Infection and Sepsis in Kidney Transplanted Patients;Biomedicines;2022-03-18
5. The applications of DNA methylation as a biomarker in kidney transplantation: a systematic review;Clinical Epigenetics;2022-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3